🇺🇸 AG-013736 in United States

27 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dehydration — 5 reports (18.52%)
  2. Enteritis — 3 reports (11.11%)
  3. Fatigue — 3 reports (11.11%)
  4. Pneumonia — 3 reports (11.11%)
  5. Respiratory Failure — 3 reports (11.11%)
  6. Abdominal Pain — 2 reports (7.41%)
  7. Acidosis — 2 reports (7.41%)
  8. Hypertension — 2 reports (7.41%)
  9. Liver Function Test Abnormal — 2 reports (7.41%)
  10. Mucosal Inflammation — 2 reports (7.41%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is AG-013736 approved in United States?

AG-013736 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for AG-013736 in United States?

University of Wisconsin, Madison is the originator. The local marketing authorisation holder may differ — check the official source linked above.